Friday 6 November 2026
Export PNTG’s income statement to Excel — free account
The Pennant Group, Inc.
PNTG Healthcare Medical Care Facilities
The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024.
- Revenue
- +32.0%
- EPS
- +55.6%
- Free cash flow
- −3.19%
- Total debt
- +662.8%
Quarter to September 2026, against a year earlier
36.58
3.42
−8.55%
Follow PNTG
Alert me
| Sep '26 From the 10-Q filed 4 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 5 | 6 | 6 |
+8 more TTM periods Free account |
| 9.41% | 8.76% | 8.51% | 8.62% | ||
| 3.99% | 3.61% | 3.57% | 3.59% | ||
ROIC |
7.14% | 6.63% | 6.38% | 6.11% | |
Return on Tangible Assets |
29.72% | 30.35% | 34.37% | 36.46% | |
Average Days of Receivables |
40.65 | 44.12 | 43.81 | 47.41 | |
Free Cash Flow per Share |
0.98 | 1.00 | 1.46 | 1.05 | |
Free Cash Flow |
34.35 | 34.68 | 50.77 | 36.26 | |
Capital Expenditures |
(30.15) | (18.62) | (15.35) | (12.04) | |
| Other line items | |||||
Cash ROIC |
5.40% | 5.62% | 9.00% | 6.42% | |
Accounts Receivable Turnover |
10.36 | 9.63 | 9.40 | 9.27 | |
Accounts Payable Turnover |
41.24 | 41.77 | 42.43 | 37.22 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
9.91 | 10.09 | 9.43 | 11.24 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.26) | (0.27) | (0.26) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.92% | 7.26% | 7.42% | 7.50% | |
Share Based Compensation of Revenue |
0.93% | 0.91% | 0.91% | 0.94% | |
Interest Coverage |
5.15 | 5.82 | 6.62 | 7.77 | |
Operating CF/Net income |
1.80 | 1.65 | 2.18 | 1.63 | |
Depreciation/Fixed assets |
0.14 | 0.15 | 0.16 | 0.15 | |
Capex/Depreciation |
(2.34) | (1.66) | (1.50) | (1.28) | |
Revenue per Share |
33.57 | 31.63 | 29.47 | 27.42 | |
Operating CF per Share |
1.84 | 1.53 | 1.90 | 1.40 | |
Capex per Share |
(0.86) | (0.53) | (0.44) | (0.35) | |
Capex to Sales |
0.03 | 0.02 | 0.02 | 0.01 |
Columns are period end dates · fundamentals updated 4 Nov 2026